Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)
07 Octobre 2021 - 3:29PM
Edgar (US Regulatory)
Filed
by Big Cypress Acquisition Corp.
pursuant
to Rule 425 under the Securities Act of 1933
and
deemed filed pursuant to Rule 14a-12
under
the Securities Exchange Act of 1934
Subject
Company: Big Cypress Acquisition Corp.
Commission
File No.: 001-39871
Date:
October 6, 2021
This filing relates
to the proposed business combination of Big Cypress Acquisition Corp. (the “Company”) and SAB Biotherapeutics, Inc. The following
communication was posted by Samuel J. Reich, Chief Executive Officer of the Company, on social media platforms LinkedIn and Twitter,
on October 6, 2021.
Big Cypress Acquisition (NASDAQ:BCYPU)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Big Cypress Acquisition (NASDAQ:BCYPU)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Big Cypress Acquisition Corporation (NASDAQ): 0 recent articles
Plus d'articles sur Big Cypress Acquisition Corp.